The issue with TBI is that it is a significantly greater heterogeneous mess of pathologies (haemorrhage, diffuse axonal injury, soup of cytotoxic electrolytes and proteins). Very different from neurodevelopmental. I think they would be nuts to do TBI before other possibilities, eg Autism.
That doesnt mean i dont think it will work (a bit), but it does mean i think its less likely to be a success trial than neurodevelopmental.
Acadia, page-174
-
- There are more pages in this discussion • 504 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.20 |
Change
0.850(5.92%) |
Mkt cap ! $1.927B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $15.24 | $14.35 | $6.244M | 417.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 798 | $15.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 630 | 9 |
View Market Depth
| Last trade - 15.51pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |